Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CERS3 antisense RNA 1 (CERS3-AS1)
- Target
- CERS3-AS1
- Molecular classification
- Long non-coding RNA, lncRNA, Antisense RNA
01
Overview
CERS3 antisense RNA 1 (CERS3-AS1) is a long non-coding RNA gene classified as an antisense transcript relative to the protein-coding CERS3 gene on chromosome 15. It does not produce a protein but may regulate the expression of CERS3 or other genes through RNA-RNA interactions or chromatin modifications. While lncRNAs are increasingly recognized for their diverse regulatory roles in gene expression, cellular proliferation, apoptosis, and migration, specific functions or mechanistic details for CERS3-AS1 remain largely uncharacterized in the current literature. There are no known drugs that target this RNA, nor is it considered a therapeutic target, biomarker, or source of major safety concerns at present.
02
Mechanism of action
Not applicable; no known drug mechanism for this lncRNA
03
Biological functions
Regulation of gene expression (by antisense mechanism)Possibly involved in cell proliferation, apoptosis, and migration (by analogy to functions of other lncRNAs and data from gene summary)
04
Disease associations
Other (Potentially regulates disease states via modulation of CERS3 or cellular processes; not directly implicated as a major driver in specific pathologies)
Beyond the preview
Go deeper on CERS3 antisense RNA 1 (CERS3-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CERS3 antisense RNA 1 (CERS3-AS1).